Reshma Kewalramani
Director, CEO & President · 6 filings · Latest: Feb 27, 2026
VERTEX PHARMACEUTICALS INC / MA
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
VRTX | Reshma Kewalramani | Director, CEO & President | Feb 27, 2026 | Sale | $493.47 | 40,000 | $19.7M | 98,278 | |
VRTX | Kewalramani Reshma | — | Feb 27, 2026 | Proposed Sale | $493.47 | 40,000 | $19.7M | — | |
VRTX | Kewalramani Reshma | — | Nov 8, 2024 | Proposed Sale | $515.00 | 15,198 | $7.8M | — |